Saccharomyces cerevisiae sepsis in a 35-week-old premature infant. A case report

M. A. Ipson, Cynthia Blanco

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Saccharomyces cerevisiae (brewer's or baker's yeast) is an extremely rare cause of fungal sepsis. It is an asporogenous yeast that is used in the production of baked goods, beer, wine, and occasionally found in health foods. It colonizes the human respiratory tract, gastrointestinal tract, urinary tract, and vagina. Severe immunosuppression, prolonged hospitalization, prior antibiotic therapy, and prosthetic cardiac valves are the settings where Saccharomyces infection has been observed. S. cerevisiae has been classified within the yeast species as a new or emerging pathogen since 1990. Increasing case reports in the medical literature are an indication of emerging yeast infections.23 In this report we will describe a 35-week-old neonate who had feeding intolerance and frequent episodes of presumed sepsis treated empirically with vancomycin, cefotaxime, and gentamicin. The patient had no other underlying problems, or central venous catheters.

Original languageEnglish (US)
Pages (from-to)459-460
Number of pages2
JournalJournal of Perinatology
Volume21
Issue number7
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Premature Infants
Saccharomyces cerevisiae
Sepsis
Yeasts
Saccharomyces
Cefotaxime
Central Venous Catheters
Heart Valves
Vagina
Wine
Vancomycin
Gentamicins
Urinary Tract
Respiratory System
Immunosuppression
Gastrointestinal Tract
Hospitalization
Newborn Infant
Anti-Bacterial Agents
Food

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health

Cite this

Saccharomyces cerevisiae sepsis in a 35-week-old premature infant. A case report. / Ipson, M. A.; Blanco, Cynthia.

In: Journal of Perinatology, Vol. 21, No. 7, 2001, p. 459-460.

Research output: Contribution to journalArticle

@article{e9c83613d4f4426c9b866a9dfe3f766e,
title = "Saccharomyces cerevisiae sepsis in a 35-week-old premature infant. A case report",
abstract = "Saccharomyces cerevisiae (brewer's or baker's yeast) is an extremely rare cause of fungal sepsis. It is an asporogenous yeast that is used in the production of baked goods, beer, wine, and occasionally found in health foods. It colonizes the human respiratory tract, gastrointestinal tract, urinary tract, and vagina. Severe immunosuppression, prolonged hospitalization, prior antibiotic therapy, and prosthetic cardiac valves are the settings where Saccharomyces infection has been observed. S. cerevisiae has been classified within the yeast species as a new or emerging pathogen since 1990. Increasing case reports in the medical literature are an indication of emerging yeast infections.23 In this report we will describe a 35-week-old neonate who had feeding intolerance and frequent episodes of presumed sepsis treated empirically with vancomycin, cefotaxime, and gentamicin. The patient had no other underlying problems, or central venous catheters.",
author = "Ipson, {M. A.} and Cynthia Blanco",
year = "2001",
doi = "10.1038/sj.jp.7200497",
language = "English (US)",
volume = "21",
pages = "459--460",
journal = "Journal of Perinatology",
issn = "0743-8346",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Saccharomyces cerevisiae sepsis in a 35-week-old premature infant. A case report

AU - Ipson, M. A.

AU - Blanco, Cynthia

PY - 2001

Y1 - 2001

N2 - Saccharomyces cerevisiae (brewer's or baker's yeast) is an extremely rare cause of fungal sepsis. It is an asporogenous yeast that is used in the production of baked goods, beer, wine, and occasionally found in health foods. It colonizes the human respiratory tract, gastrointestinal tract, urinary tract, and vagina. Severe immunosuppression, prolonged hospitalization, prior antibiotic therapy, and prosthetic cardiac valves are the settings where Saccharomyces infection has been observed. S. cerevisiae has been classified within the yeast species as a new or emerging pathogen since 1990. Increasing case reports in the medical literature are an indication of emerging yeast infections.23 In this report we will describe a 35-week-old neonate who had feeding intolerance and frequent episodes of presumed sepsis treated empirically with vancomycin, cefotaxime, and gentamicin. The patient had no other underlying problems, or central venous catheters.

AB - Saccharomyces cerevisiae (brewer's or baker's yeast) is an extremely rare cause of fungal sepsis. It is an asporogenous yeast that is used in the production of baked goods, beer, wine, and occasionally found in health foods. It colonizes the human respiratory tract, gastrointestinal tract, urinary tract, and vagina. Severe immunosuppression, prolonged hospitalization, prior antibiotic therapy, and prosthetic cardiac valves are the settings where Saccharomyces infection has been observed. S. cerevisiae has been classified within the yeast species as a new or emerging pathogen since 1990. Increasing case reports in the medical literature are an indication of emerging yeast infections.23 In this report we will describe a 35-week-old neonate who had feeding intolerance and frequent episodes of presumed sepsis treated empirically with vancomycin, cefotaxime, and gentamicin. The patient had no other underlying problems, or central venous catheters.

UR - http://www.scopus.com/inward/record.url?scp=0034779678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034779678&partnerID=8YFLogxK

U2 - 10.1038/sj.jp.7200497

DO - 10.1038/sj.jp.7200497

M3 - Article

VL - 21

SP - 459

EP - 460

JO - Journal of Perinatology

JF - Journal of Perinatology

SN - 0743-8346

IS - 7

ER -